{
  "paper_id": "188f3e97042155ac1709aa8b74c0755760c3b50d",
  "metadata": {
    "title": "14:1022; www.ecancer.org",
    "coda_data_split": "train",
    "coda_paper_id": 5969,
    "coda_has_expert_labels": false,
    "subset": "comm_use_subset"
  },
  "abstract": [
    {
      "original_text": "Cancer and transplant patients with COVID-19 have a higher risk of developing severe and even fatal respiratory diseases, especially as they may be treated with immune-suppressive or immune-stimulating drugs. This review focuses on the effects of these drugs on host immunity against COVID-19.",
      "sentences": [
        [
          {
            "segment_text": "Cancer and transplant patients with COVID-19 have a higher risk of developing severe and even fatal respiratory diseases ,",
            "crowd_label": "background"
          },
          {
            "segment_text": "especially as they may be treated with immune-suppressive or immune-stimulating drugs .",
            "crowd_label": "background"
          }
        ],
        [
          {
            "segment_text": "This review focuses on the effects of these drugs on host immunity against COVID-19 .",
            "crowd_label": "purpose"
          }
        ]
      ]
    }
  ],
  "abstract_stats": {
    "paragraph_num": "1",
    "sentence_num": "2",
    "segment_num": "3",
    "token_num": "46"
  }
}